Illumina (NASDAQ:ILMN) stock appears to be on course to produce its best return since 2014. That’s great news for shareholders who endured paltry gains in 2015 and a big 29% drop last year.
Is the stock still a good pick? Here are three charts that every investor who owns Illumina stock or is considering buying it needs to see to better understand the reason why the gene-sequencing leader continues to present a great opportunity.
